Connect with others who understand.

Sign up Log in
Resources
About MyVitiligoTeam
Powered By
In partnership with the Global Vitiligo Foundation ?

Vitiligo and Lupus: What’s the Connection?

Updated on May 17, 2022

People living with vitiligo have a higher risk of developing lupus than individuals in the general population. “I had vitiligo that came and went a few times in one area several years before I was diagnosed with lupus,” one MyVitiligoTeam member wrote.

It’s important to understand how these two conditions — and their treatments — may or may not be connected. This knowledge can help you manage your symptoms if you live with one or both conditions.

What Are Lupus and Vitiligo?

Lupus is a chronic autoimmune disease. An autoimmune disease is a condition in which a person’s immune system is overactive and attacks their own organs and tissues. Inflammation is one of the characteristics of lupus. This inflammation can cause damage to many parts of the body, such as the skin (resulting in discoid lupus or chronic cutaneous lupus), joints, blood cells and vessels, lungs, heart, kidneys, and brain.

Vitiligo is an inflammatory disease caused by an autoimmune reaction that leads to loss of skin pigment. This means that, like lupus, vitiligo is an autoimmune disease. People with vitiligo develop lighter skin patches because their immune systems attack and destroy melanocytes (the skin cells that make melanin, which gives skin its color). Between 15 percent and 25 percent of individuals living with vitiligo also have other autoimmune disorders, like lupus.

Types of Vitiligo and Associated Lupus

Several types of vitiligo exist. Three types are:

  • Generalized vitiligo (also known as nonsegmental vitiligo)
  • Segmental vitiligo
  • Drug-induced vitiligo

All three are the result of destroyed pigment cells in the skin.

Generalized Vitiligo

Generalized vitiligo normally occurs in symmetrical patches of skin depigmentation (discoloration). This means that both sides of the body will show discolored skin patches. Generalized vitiligo is common in people with autoimmune thyroid diseases like Hashimoto’s thyroiditis.

One study found that Caucasian populations with autoimmune disorders like hypothyroidism, Addison’s disease, inflammatory bowel disease, pernicious anemia, and systemic lupus erythematosus were more likely to also have generalized vitiligo. Another study considered the prevalence of vitiligo and autoimmune diseases, such as rheumatoid arthritis and lupus, in mestizo Mexican populations. This study found that 26 percent of individuals with vitiligo also had lupus. More studies are needed to determine the prevalence of both lupus and vitiligo in people of other races and ethnicities.

Segmental Vitiligo

Segmental (or unilateral) vitiligo affects one side of the body. Unlike generalized vitiligo, which progresses over time, segmental vitiligo can progress for a few years and then stop progressing. This type of vitiligo is usually seen in children and young adults. Linear lupus erythematosus, a type of lupus thought to be caused by an immune reaction to genetically mutated skin cells, also emerges in childhood and only progresses for a few years.

Segmental vitiligo is less often associated with autoimmune diseases (such as lupus or thyroid disease) than generalized vitiligo.

Drug-Induced Vitiligo

Drug-induced vitiligo (also called leukoderma) is similar to other types of vitiligo. With this condition, skin cells lose pigmentation as a result of medication use. People with drug-induced vitiligo are more likely to develop other autoimmune conditions, such as diabetes. However, the link between drug-induced vitiligo and lupus is still not very clear. Stopping use of the triggering medication can improve both conditions.

A study looking at comorbidities (conditions related to vitiligo) in a large number of people with vitiligo showed that 2.2 percent of individuals with vitiligo had lupus. Vitiligo and lupus share several risk factors, including certain medications, genetic risk factors, and environmental factors.

Medications

Although many different types of drugs are known to trigger drug-induced vitiligo, the pathogenesis of the disease (how it begins and develops) is still not fully understood. Some theories suggest that it may be an autoimmune reaction. Other theories suggest that the medications could adversely affect the nervous system or be toxic to cells.

Hundreds of drugs have been identified to cause drug-induced lupus. However, exactly how drug-induced lupus develops is also a topic of debate. Drug-induced vitiligo and drug-induced lupus can often be caused by the same medications, such as TNF-alpha inhibitors. These medications suppress the immune system by blocking the activity of TNF-alpha, a protein that causes inflammation.

Genetic Risk Factors

Some scientists think genetic risk factors make it more likely for a person to develop vitiligo and lupus. A genetic risk factor is often referred to as genetic predisposition or susceptibility to a disease.

The genetic risk factors associated with both diseases include some HLA genes. These genes code for proteins that regulate the immune system. Because a person’s genetic makeup can predispose them to develop either disease, it is not surprising that people with family members who have either disease have an increased risk of developing the disease themselves.

Environmental Factors

Environmental factors can also trigger both vitiligo and lupus in people who are genetically predisposed to these conditions. Excessive sun exposure and certain chemicals, such as cosmetic dyes, are shared triggers for both conditions.

Does Treatment for Vitiligo Impact Treatment for Lupus (or Vice Versa)?

When living with both vitiligo and lupus, it is important to understand how treatment options for one condition can affect the other. Some medications, such as corticosteroids, may be beneficial in treating both conditions. However, a treatment option for one disease may interfere with the treatment of the other.

A common therapy option for individuals with vitiligo is narrow-band ultraviolet-B therapy. However, short ultraviolet-B wavelengths can be harmful to people with systemic lupus erythematosus, as these individuals are more sensitive to sunlight.

Many people living with lupus are prescribed chloroquine. Although this is a well-known treatment for managing lupus, drug-induced vitiligo has been reported in people with cutaneous lupus erythematosus who took chloroquine.

Always speak with your physician before beginning any treatment. This way, they can be aware of how different medications and other treatments may interact with conditions that you have.

Talk With Others Who Understand

MyVitiligoTeam is the social network for people with vitiligo and their loved ones. On MyVitiligoTeam, more than 9,000 members come together to ask questions, give advice, and share their stories with others who understand life with vitiligo.

Do you have vitiligo and lupus? Share your experience in the comments below, or start a conversation by posting on your Activities page.

In partnership with the Global Vitiligo Foundation, which strives to improve the quality of life for individuals with vitiligo through education, research, clinical care, and community support.

References
  1. Comorbid Autoimmune Diseases in Patients With Vitiligo: A Cross-Sectional Study — Journal of the American Academy of Dermatology
  2. Lupus — Mayo Clinic
  3. Inflammatory Changes in Vitiligo: Stage I and II Depigmentation — American Journal of Dermatopathology
  4. Vitiligo — Cleveland Clinic
  5. The Genetics of Generalized Vitiligo and Associated Autoimmune Diseases — Journal of Dermatological Science
  6. Vitiligo — MedlinePlus
  7. Vitiligo and Autoimmune Thyroid Disorders — Frontiers in Endocrinology
  8. Epidemiology of Vitiligo and Associated Autoimmune Diseases in Caucasian Probands and Their Families — Pigment Cell Research
  9. Hypothyroidism (Underactive) — American Thyroid Association
  10. Addison’s Disease — Mayo Clinic
  11. Pernicious Anemia — MedlinePlus
  12. Autoimmune Vitiligo in Rheumatic Disease in the Mestizo Mexican Population — Biomedical Reports
  13. Vitiligo: A Review of Some Facts Lesser Known About Depigmentation — Indian Journal of Dermatology
  14. Autoimmunity in Segmental Vitiligo — Frontiers in Immunology
  15. Segmental Vitiligo — Dermatologic Clinics
  16. Drug-Induced Vitiligo — DermNet NZ
  17. Drug-Induced Lupus Erythematosus — StatPearls
  18. Update on the Genetics Characterization of Vitiligo — International Journal of Health Sciences
  19. Understanding the Genetics of Lupus — Lupus Foundation of America
  20. Understanding Lupus Environmental Triggers — Lupus Foundation of America
  21. Treating Lupus With Steroids — Johns Hopkins Lupus Center
  22. What Is New in Narrow-Band Ultraviolet-B Therapy for Vitiligo? — Indian Dermatology Online Journal
  23. Light Therapy (With UVA-1) for SLE Patients: Is It a Good or Bad Idea? — Rheumatology
  24. Chloroquine-Induced, Vitiligo-Like Depigmentation — Journal of the American Academy of Dermatology
  25. Comorbidities Associated With Vitiligo: A Ten-Year Retrospective Study — Dermatology
Updated on May 17, 2022

A MyVitiligoTeam Subscriber

I have been diagnosed with lupus erythematosus. What should I do and expect?

2 days ago
All updates must be accompanied by text or a picture.

We'd love to hear from you! Please share your name and email to post and read comments.

You'll also get the latest articles directly to your inbox.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service.
All updates must be accompanied by text or a picture.

Subscribe now to ask your question, get answers, and stay up to date on the latest articles.

Get updates directly to your inbox.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service.
Amit G. Pandya, M.D., Medical Advisory Board Chair of the Global Vitiligo Foundation is a dermatologist at the Palo Alto Medical Foundation in Mountain View, California. Learn more about him here.
Susana Restrepo, Ph.D. is a medical and scientific writer with a Ph.D. in pharmacology from the University of Colorado. Learn more about her here.

Recent Articles

Vitiligo has been linked to other autoimmune disorders, conditions in which the immune system mis...

7 Conditions Related to Vitiligo: Lupus, Autoimmune Thyroid Diseases, and More

Vitiligo has been linked to other autoimmune disorders, conditions in which the immune system mis...
Many people with vitiligo explore vitamin and herbal supplements to address different needs — w...

5 Facts About Vitamins for Vitiligo: Can They Help?

Many people with vitiligo explore vitamin and herbal supplements to address different needs — w...
Living Life and Love With Vitiligo Ep 6: Eric Peacock Mark Braxton, the host of Living Life an...

Living Life and Love With Vitiligo (VIDEO)

Living Life and Love With Vitiligo Ep 6: Eric Peacock Mark Braxton, the host of Living Life an...
Many members of MyVitiligoTeam have questions about vitamin D. “What is a healthy vitamin D level...

Can Vitamin D Help Treat Vitiligo?

Many members of MyVitiligoTeam have questions about vitamin D. “What is a healthy vitamin D level...
There is no cure for vitiligo, but loss of skin pigment can be managed. There are several medicat...

Vitiligo and Repigmentation Options

There is no cure for vitiligo, but loss of skin pigment can be managed. There are several medicat...
Vitiligo: The Science Within the SkinThis animated video explains what vitiligo is and the tw...

The Science of Vitiligo (VIDEO)

Vitiligo: The Science Within the SkinThis animated video explains what vitiligo is and the tw...

Thank you for subscribing!

Become a member to get even more: